50371
47453
S&P/TSX
16298.88
-72.93
(-0.45%)
S&P-CDNX
888.27
-7.92
(-0.88%)
S&P-500
2776.42
-9.82
(-0.35%)
NASDAQ
7223.69
-37.38
(-0.51%)
Dow
25792.86
-10.33
(-0.04%)
Dollar
0.8032
-0.00165
(-0.205%)
Oil
63.77
+0.04
(+0.06%)
Gold
1334.40
-2.70
(-0.20%)
Silver
17.150
-0.039
(-0.23%)


Valeant to sell Obagi

Valeant Pharmaceuticals International, Inc. (TSX:VRX) has a deal to sell its Obagi skin care business to a Hong Kong-based group for US$190 million in cash.

The Quebec-based company, headquartered in Laval, estimates its Obagi Medical Products unit will generate about US$85 million of revenue in 2017.

The buyer is a fund managed by a limited partnership that includes China Regenerative Medicine International and Haitong International Securities Group, both headquartered in Hong Kong.



More Business News

49471
Recent Trending
48655
Okanagan Oldies
50605
Castanet Proud Member of RTNDA Canada
Press Room
50617